AIRLINK 59.00 Increased By ▲ 0.50 (0.85%)
BOP 6.27 Increased By ▲ 0.01 (0.16%)
CNERGY 4.18 Increased By ▲ 0.22 (5.56%)
DFML 16.25 Increased By ▲ 0.24 (1.5%)
DGKC 68.11 Decreased By ▼ -0.44 (-0.64%)
FCCL 18.12 Increased By ▲ 0.27 (1.51%)
FFBL 25.64 Increased By ▲ 0.14 (0.55%)
FFL 9.29 Increased By ▲ 0.09 (0.98%)
GGL 10.02 Increased By ▲ 0.22 (2.24%)
HBL 115.10 Increased By ▲ 1.10 (0.96%)
HUBC 112.80 Increased By ▲ 0.95 (0.85%)
HUMNL 6.65 Increased By ▲ 0.12 (1.84%)
KEL 4.46 Increased By ▲ 0.09 (2.06%)
KOSM 4.80 Increased By ▲ 0.21 (4.58%)
MLCF 38.19 Increased By ▲ 0.39 (1.03%)
OGDC 127.70 Increased By ▲ 2.26 (1.8%)
PAEL 22.73 Increased By ▲ 0.18 (0.8%)
PIAA 11.22 Increased By ▲ 0.09 (0.81%)
PIBTL 6.30 Increased By ▲ 0.12 (1.94%)
PPL 109.60 Increased By ▲ 0.60 (0.55%)
PRL 27.78 Increased By ▲ 0.97 (3.62%)
PTC 10.92 Increased By ▲ 0.37 (3.51%)
SEARL 53.40 Increased By ▲ 0.70 (1.33%)
SNGP 67.50 Increased By ▲ 1.15 (1.73%)
SSGC 11.09 Increased By ▲ 0.07 (0.64%)
TELE 7.18 Increased By ▲ 0.04 (0.56%)
TPLP 11.93 Decreased By ▼ -0.07 (-0.58%)
TRG 77.74 Increased By ▲ 1.29 (1.69%)
UNITY 21.67 Increased By ▲ 1.26 (6.17%)
WTL 1.30 Decreased By ▼ -0.01 (-0.76%)
BR100 6,510 Increased By 68.9 (1.07%)
BR30 22,413 Increased By 314.3 (1.42%)
KSE100 63,505 Increased By 689 (1.1%)
KSE30 21,382 Increased By 248.7 (1.18%)

EDITORIAL: What has happened in Punjab is beyond shocking. Several diabetes patients seeking treatment for retinal atrophy have been injected with contaminated version of a drug, Avastin, resulting in loss of vision.

It turns that taking advantage of high prices of medicine due to steep rupee depreciation, some unscrupulous distributors had been selling Avastin, manufactured by the reputable Swiss pharmaceutical company, Roche, repackaging it in small doses and sell on cheap rates.

True to their norm, the Drug Regulatory Authority of Pakistan (DRAP), along with provincial health authorities, has spurred into action after the event and formed a high level committee to investigate the sale of “altered/dispensed/diluted” form of Avastin injection.

Suspected batches of the drug have been recalled and further distribution stopped till verification of its quality through sampling and laboratory testing.

Meanwhile, Roche has issued a statement, saying the drug in question is approved by regulatory authorities in as many as 130 countries, including the US, for treatment of various types of cancer, assuring the local health authorities of its cooperation to protect patients from counterfeits. The statement also points out that “Avastin is not approved for any use in the eye.”

It is imperative therefore to investigate as to why it was allowed to be used for eye treatment. Now that the matter is under public scrutiny, in an apparent bid to cover up its own adequacies the DRAP has claimed that in the cases concerned Avastin was used off-label, thereby suggesting that it was applied for eye conditions without its approval. In that event, the provincial health department has to answer for overlooking the misuse.

The sad reality though is that fake/counterfeit drugs, including life-saving ones, are freely produced and sold in plain sight of drug inspectors. Some black sheep among the medical practitioners are not without blame, either.

There is the example of surgeon(s) at a major Lahore hospital caught recommending a certain substandard stent for heart patients. In another instance, several patients died after consuming a cost-free contaminated medicine obtained from a government cardiology hospital in the city.

Following the latest wrongdoing, the health authorities have suspended 12 drug inspectors and deputy drug controllers for negligence.

This is not enough. It is about time governments in Punjab and other provinces took serious action against all manufacturers and marketers of spurious/counterfeit drugs. All involved in this criminal enterprise ought to be handed exemplary punishment.

The least the health authorities owe to the people is a result-oriented crackdown on remorseless elements posing health risks to unsuspecting consumers. Regarding the present case, the government must do all that is necessary to provide the victims of unforgivable malefactors with any available corrective treatment.

Copyright Business Recorder, 2023


Comments are closed.

Tariq Qurashi Sep 28, 2023 10:54am
There are counterfeit drugs, and counterfeit implants, and counterfeit knee joints, and unnecessary operations and unnecessary tests. This business has been going on for many years, but I have never seen a pharmacist, fake drug manufacturer, doctor, DRAP official, or drug inspector go to jail. If you don't punish people the problem will only get worse.
thumb_up Recommended (0)
KU Sep 28, 2023 12:04pm
Like other corrupt sectors, the fake medicine business has been thriving for as long as the history of our country. If the author was to research the rural area, it would be mind-boggling because the majority of the medicines are fake, while expired medicines end up being sold in all the tehsil villages. And no one to stop it or give a hoot about it.
thumb_up Recommended (0)